| BRAIN AG. (3/7/18). "Press Release: BRAIN, AnalytiCon Discovery and Roquette Reach Major Milestone in DOLCE Program for Natural- based Sugar and Calorie Reduction in Food and Beverages Faster than Originally Expected". Zwingenberg, Potsdam & La Madeleine |
2018-03-07 |
| Selexis S.A.. (3/7/18). "Press Release: Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the Development of Antibody-Based Therapeutics". Geneva. |
2018-03-07 |
| Celgene Corporation. (3/6/18). "Press Release: Celgene Completes Acquisition of Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy". Summit, NJ. |
2018-03-06 |
| Curetis N.V.. (3/6/18). "Press Release: Curetis Subsidiary Ares Genetics Wins Incubator Stay in Silicon Valley". Amsterdam & San Diego, CA & Holzgerlingen. |
2018-03-06 |
| Novartis AG. (3/6/18). "Press Release: Novartis' Xolair Recommended in New Global Chronic Urticaria Guideline". Basel. |
2018-03-06 |
| BRAIN AG. (3/6/18). "Press Release: BRAIN AG Establishes US Subsidiary to Strengthen Business Development in North America". Zwingenberg. |
2018-03-06 |
| Eurofins Scientific. (3/6/18). "Press Release: Eurofins Exceeds Its Recently-upgraded 2017 Objectives on a Strong Growth Momentum and Raises Its Objectives for 2018". |
2018-03-06 |
| BIA Separations d.o.o.. (3/5/18). "Press Release: BIA Separations and Nuvonis Technologies Partner to Support Vaccine and Gene Therapy Production". Ajdovšcina & Vienna. |
2018-03-05 |
| Heidelberg Pharma AG. (3/5/18). "Press Release: Heidelberg Pharma and Magenta Therapeutics Sign Exclusive MultiTarget Research Agreement for the Development of Antibody Drug Conjugates". Ladenburg & Cambridge, MA. |
2018-03-05 |
| G1 Therapeutics, Inc.. (3/5/18). "Press Release: G1 Therapeutics Announces Positive Trilaciclib Phase 2a Topline Data Showing Robust Myelopreservation Benefits in Patients with Small Cell Lung Cancer". Research Triangle Park, NC. |
2018-03-05 |
| Addex Therapeutics S.A.. (3/5/18). "Press Release: Addex Secures Investor Commitment for CHF40 Million Capital Increase Following Successful Completion of Book Building Process". Geneva. |
2018-03-05 |
| ViraTherapeutics GmbH. (3/5/18). "Press Release: ViraTherapeutics Starts Second Oncolytic Virus Development Program with Boehringer Ingelheim". Innsbruck. |
2018-03-05 |
| Business France. (3/2/18). "Press Release: Biotechnology and Laboratory Technology from France at Analytica". |
2018-03-02 |
| Heidelberg Pharma AG. (3/1/18). "Press Release: Heidelberg Pharma Signs License Agreement with The University of Texas MD Anderson Cancer Center". Ladenburg. |
2018-03-01 |
| Affiris AG. (3/1/18). "Press Release: Affiris Announces Results of a Phase I Clinical Study Using Affitopes PD01A and PD03A, Confirming Safety and Tolerability for Both Compounds as well as Immunogenicity for PD01A in Early MSA patients". Vienna. |
2018-03-01 |
| Bruker Corporation. (3/1/18). "Press Release: Bruker Names Burkhard Prause, President of Bruker Energy & Supercon Technologies (BEST), an Executive Officer of Bruker Corporation". Billerica, MA. |
2018-03-01 |
| Basilea Pharmaceutica Ltd.. (3/1/18). "Press Release: Basilea Names Adesh Kaul as New Member of its Management Committee". Basel. |
2018-03-01 |
| Enzymicals AG. (3/1/18). "Press Release: Signed Cooperation Agreement. Special Chemical Manufacturers abcr GmbH and Enzymicals AG Want to Make Use of Synergies". Greifswald & Karlsruhe. |
2018-03-01 |
| R-Biopharm AG. (3/1/18). "Press Release: R-Biopharm AG & Bosch Healthcare Solutions Partner to Develop Molecular Diagnostics for Automated All-in-One Platform". Darmstadt & Waiblingen. |
2018-03-01 |
| BioMedPartners AG. (3/1/18). "Press Release: BioMedPartners Close Their New Healthcare Venture Fund BioMedInvest III at CHF 100 Million". Basel. |
2018-03-01 |
| Rentschler Biopharma SE. (2/28/18). "Press Release: Rentschler Biopharma SE Appoints Federico Pollano as Senior Vice President, Business Development". Laupheim. |
2018-02-28 |
| BRAIN AG. (2/28/18). "Press Release: BRAIN AG Starts the Financial Year 2017/18 with a Weak First Quarter". Zwingenberg. |
2018-02-28 |
| ERS Genomics Ltd.. (2/28/18). "Press Release: European Patent Office Grants Second Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications". Dublin. |
2018-02-28 |
| German Accelerator Life Sciences. (2/28/18). "Press Release: German Accelerator Life Sciences Appoints Vice President Germany". Berlin & Cambridge, MA. |
2018-02-28 |
| Thermo Fisher Scientific Inc.. (2/28/18). "Press Release: Thermo Fisher Supplies Analytical Instruments to World Anti-Doping Agency Laboratory in South Korea". Waltham, MA. |
2018-02-28 |
| Novo Holdings A/S. (2/27/18). "Press Release: Novo Holdings Launches USD 165m Impact Fund to Combat Antimicrobial Resistance". Copenhagen. |
2018-02-27 |
| Basilea Pharmaceutica Ltd.. (2/27/18). "Press Release: Basilea Reports Significantly Improved Financial Results in 2017". Basel. |
2018-02-27 |
| Hume Brophy. (2/27/18). "Press Release: Hume Brophy International Healthcare Launches New Life Sciences Division". London. |
2018-02-27 |
| Selexis S.A.. (2/26/18). "Press Release: Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates". Geneva. |
2018-02-26 |
| Valneva S.E.. (2/26/18). "Press Release: Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate against Zika Virus". Gaithersburg, MD & Lyon. |
2018-02-26 |
| Bruker Corporation. (2/26/18). "Press Release: Bruker Highlights Innovative Analytical Solutions and Systems at Pittcon". Orlando, FL. |
2018-02-26 |
| Berlin Cures Holding AG. (2/26/18). "Press Release: Heart Failure Treatment from Berlin Cures Shows Promise in Phase 1 Study". Zug & Berlin. |
2018-02-26 |
| Miltenyi Biotec GmbH. (2/26/18). "Press Release: MolMed and Miltenyi Biotec. EMA Approves the Utilization of the CliniMACS Prodigy Equipment". Milan & Bergisch Gladbach. |
2018-02-26 |
| AiCuris Anti-infective Cures GmbH. (2/23/18). "Press Release: AiCuris’ Licensee MSD Launches Prevymis (letermovir) in Germany". Wuppertal. |
2018-02-23 |
| Basilea Pharmaceutica Ltd.. (2/23/18). "Press Release: Basilea Reports Clinical Phase 3 Study Start with Antibiotic Ceftobiprole in Skin Infections under BARDA Contract". Basel. |
2018-02-23 |
| BCNP Consultants GmbH. (2/23/18). "Press Release: More than 1,200 Meetings at the 2nd European Chemistry Partnering". Frankfurt a. M.. |
2018-02-23 |
| Qiagen N.V.. (2/23/18). "Press Release: Qiagen Opens Shared Services Center in Taguig City, Manila". Manila. |
2018-02-23 |
| Streck, Inc.. (2/23/18). "Press Release: Streck, Inc. Files Suit against Cenata GmbH for Infringement of Its European Patent". La Vista, NE. |
2018-02-23 |
| BRAIN AG. (2/22/18). "Press Release: BRAIN AG Expands Patent Protection for Unique Taste Cell Technology to Europe". |
2018-02-22 |
| Bruker Corporation. (2/22/18). "Press Release: Bruker Acquires High-Speed QCL Infrared Microscopy Company IRM²". Ettlingen. |
2018-02-22 |
| Medigene AG. (2/21/18). "Press Release: Medigene Receives Approvals for Its First Clinical Trial with TCR Therapy MDG1011". Planegg. |
2018-02-21 |
| Basilea Pharmaceutica Ltd.. (2/21/18). "Press Release: Basilea's CEO Ronald Scott Will Retire. Chief Commercial Officer David Veitch Named as Successor – Changes in the Board of Directors". Basel. |
2018-02-21 |
| Bruker Corporation. (2/21/18). "Press Release: Bruker Announces Resignation of Chief Financial Officer and Appointment of Principal Accounting Officer". Billerica, MA. |
2018-02-21 |
| G1 Therapeutics, Inc.. (2/21/18). "Press Release: G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights". Research Triangle Park, NC. |
2018-02-21 |
| Merck KGaA. (2/21/18). "Press Release: Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia". Darmstadt. |
2018-02-21 |
| Cullinan Oncology, LLC. (2/20/18). "Press Release: Cullinan Oncology and MAB Discovery Announce Collaboration to Develop Novel Antibody-Based Therapeutics". Cambridge, MA & Neuried. |
2018-02-20 |
| Bruker Corporation. (2/20/18). "Press Release: Bruker Announces Quarterly Dividend". Billerica, MA. |
2018-02-20 |
| Minoryx Therapeutics S.L.. (2/20/18). "Press Release: Minoryx Therapeutics Spins Off SEE-Tx Platform into New Company, Gain Therapeutics". Mataró, Barcelona & Lugano. |
2018-02-20 |
| Siemens AG. (2/19/18). "Press Release: Siemens Plans IPO of Siemens Healthineers AG in the First Half of Calendar Year 2018 [Not for United States, Australia, Canada or Japan]". Erlangen & Munich. |
2018-02-19 |
| Avillion LLP. (2/16/18). "Press Release: Avillion Advances Co-development Programme with Merck. IND Now Open for Phase 2 Study of M1095, an anti-IL-17 A/F Nanobody in Psoriasis". London. |
2018-02-16 |
| Pieris Pharmaceuticals, Inc.. (2/16/18). "Press Release: Pieris Pharmaceuticals Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares". Boston, MA. |
2018-02-16 |
| Affimed N.V.. (2/15/18). "Press Release: Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares". Heidelberg. |
2018-02-15 |
| Addex Therapeutics S.A.. (2/15/18). "Press Release: Addex Launches CHF40 million Capital Increase with Commitments from Specialist US Healthcare Investors". Geneva. |
2018-02-15 |
| Roche. (2/15/18). "Press Release: Roche to Acquire Flatiron Health to Accelerate Industry-wide Development and Delivery of Breakthrough Medicines for Patients with Cancer". Basel. |
2018-02-15 |
| Merck KGaA. (2/15/18). "Press Release: Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer [Not intended for UK-based media]". Darmstadt. |
2018-02-15 |
| ABAC Therapeutics. (2/15/18). "Press Release: ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-resistant Bacteria". Barcelona. |
2018-02-15 |
| Cell Medica Ltd.. (2/15/18). "Press Release: Cell Medica Announces the Appointment of Kevin Boyle as Chief Financial Officer". |
2018-02-15 |
| Bruker Corporation. (2/14/18). "Press Release: The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology". Billerica, MA. |
2018-02-14 |
| Recipharm AB. (2/14/18). "Press Release: Recipharm Appoints President Development Services to Drive End to End Offering". |
2018-02-14 |
| Affimed N.V.. (2/13/18). "Press Release: Affimed Announces Pricing of Public Offering of Common Stock". Heidelberg. |
2018-02-13 |
| Gilde Healthcare Partners. (2/13/18). "Press Release: Gilde Healthcare Company RAD-x Continues Buy & Build with Acquisition of Swiss Medical Imaging Centers". Utrecht. |
2018-02-13 |
| Sciomics GmbH. (2/12/18). "Press Release: Sciomics Participates in Collaborative Clinical Trials for the Treatment of Metaphyseal Chondrodysplasia Type Schmid (MCDS)". Heidelberg. |
2018-02-12 |
| Affimed N.V.. (2/12/18). "Press Release: Affimed Announces Proposed Public Offering of Common Stock". Heidelberg. |
2018-02-12 |
| Lonza Group AG. (2/12/18). "Press Release: Lonza Expands Cell-Culture Portfolio with Quasi Vivo System". Basel. |
2018-02-12 |
| Pieris Pharmaceuticals, Inc.. (2/9/18). "Press Release: Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration". Boston, MA & Bothell, WA. |
2018-02-09 |
| Boehringer Ingelheim. (2/9/18). "Press Release: Boehringer Ingelheim Refocuses PDE9 Inhibition Brain Research on Schizophrenia Following Results from Phase II Alzheimer’s Trials". Ingelheim. |
2018-02-09 |
| Bruker Corporation. (2/8/18). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2017 Financial Results". Billerica, MA. |
2018-02-08 |
| Fluidigm Corporation. (2/8/18). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress". South San Francisco, CA. |
2018-02-08 |
| Genedata AG. (2/8/18). "Press Release: Genedata Bioprocess Licensed to Pfizer Inc.". Basel. |
2018-02-08 |
| Lonza Group Ltd.. (2/8/18). "Press Release: Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines". Basel & South San Francisco, CA. |
2018-02-08 |
| University of Bayreuth. (2/8/18). "Press Release: Innovative Research Infrastructure with a Global Reputation. The Northern Bavarian NRM Centre Repositions Itself". |
2018-02-08 |
| c-LEcta GmbH. (2/8/18). "Press Release: c-LEcta Closes Exclusive Supply Agreement with Global Pharma Company". |
2018-02-08 |
| Ablynx N.V.. (2/7/18). "Press Release: Ablynx Announces Board Changes". Ghent. |
2018-02-07 |
| Addex Therapeutics S.A.. (2/7/18). "Press Release: Addex Appoints Jean-Philippe Rocher as Co-Head of Discovery and Member of the Executive Management". Geneva. |
2018-02-07 |
| Analytik Jena AG. (2/7/18). "Press Release: Laboratory Automation Solution Designed to Boost Productivity Showcased at SLAS 2018". San Diego, CA & Jena. |
2018-02-07 |
| Lonza Group Ltd.. (2/7/18). "Press Release: Lonza Partners with Prolog Ventures to Establish VC Fund to Invest in Consumer Health and Wellness Startups". Basel. |
2018-02-07 |
| Sanofi S.A.. (2/7/18). "Press Release: Sanofi Delivers 2017 Business EPS(1) in Line with Guidance". Paris. |
2018-02-07 |
| ProBioGen AG. (2/7/18). "Press Release: ProBioGen and Teva Sign License Agreement on Human Artificial Lymph Node Technology". Berlin. |
2018-02-07 |
| ImmunoQure AG. (2/6/18). "Press Release: Servier and ImmunoQure AG Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody". Paris & Düsseldorf. |
2018-02-06 |
| Genedata AG. (2/6/18). "Press Release: Genedata Announces New Solution for NGS-Based Biosafety Assessment". Basel. |
2018-02-06 |
| Idorsia Ltd.. (2/6/18). "Press Release: Idorsia Announces Financial Results for 2017 – Company Off to a Great Start – 4 Compounds to Enter Phase 3 Development". Allschwil. |
2018-02-06 |
| InflaRx N.V.. (2/6/18). "Press Release: InflaRx Announces Appointment of Tony Gibney to Its Board of Directors". Jena. |
2018-02-06 |
| Selvita S.A.. (2/6/18). "Press Release: Selvita Appoints Steffen Heeger, M.D., PhD as Chief Medical Officer". Kraków. |
2018-02-06 |
| Sophia Genetics S.A.. (2/6/18). "Press Release: Sophia Genetics Announces CE-IVD Marking of Its Genomic Test for Leukemia Detection". Lausanne. |
2018-02-06 |
| Faron Pharmaceuticals Oy. (2/5/18). "Press Release: Faron Establishes Second Traumakine Manufacturing Site". Turku. |
2018-02-05 |
| Addex Therapeutics S.A.. (2/5/18). "Press Release: Addex Provides Key Financial Indicators and Trading Update. Cash Position of CHF6.5 million as of 31 January 2018". Geneva. |
2018-02-05 |
| SGS S.A.. (2/2/18). "Press Release: SGS Acquires TraitGenetics GmbH, Germany". |
2018-02-02 |
| Genedata AG. (2/2/18). "Press Release: Genedata Profiler Powers Major Breakthroughs in Early Prediction of Breast and Ovarian Cancer". Basel. |
2018-02-02 |
| 4SC AG. (2/1/18). "Press Release: Positive DSMB Safety Review of 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL". Planegg-Martinsried. |
2018-02-01 |
| Medigene AG. (2/1/18). "Press Release: Medigene Strengthens Its Patent Portfolio with a US Patent on a Tagged TCR". Planegg. |
2018-02-01 |
| Lab Automation Network (LAN). (2/1/18). "Press Release: Cytosurge AG and Lab Automation Network Announce Partnership for Automated Single-cell Biology Applications". |
2018-02-01 |
| Life Science Inkubator GmbH. (2/1/18). "Press Release: Life Science Inkubator (LSI) Bonn for the First Time Supports Pharma Industry Spin-out". |
2018-02-01 |
| Miltenyi Biotec GmbH. (2/1/18). "Press Release: Cancer Coaching for the Immune System. Novel Cell Therapy Will Teach Immune Cells How to Fight Cancer". Teterow. |
2018-02-01 |
| Arnold & Porter LLP. (2/1/18). "Press Release: Announcing Arnold & Porter". |
2018-02-01 |
| Affimed N.V.. (2/1/18). "Press Release: Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas". Heidelberg. |
2018-02-01 |
| Qiagen N.V.. (1/31/18). "Press Release: Qiagen Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing". Germantown, MD & Hilden. |
2018-01-31 |
| Genedata AG. (1/31/18). "Press Release: Genedata Announces Genedata Screener for Massive Mechanistic Analysis". Basel. |
2018-01-31 |
| Analytik Jena AG. (1/31/18). "Press Release: SLAS 2018 — Modular Liquid Handling System CyBio FeliX Automates New Process for Nucleic Acid Extraction". Jena. |
2018-01-31 |
| Lonza Group AG. (1/31/18). "Press Release: Lonza Reports Record-breaking Full-year Results with Double-digit Lonza Standalone Sales Growth and More than 26% CORE EBIT Growth in a Major Transformational Year". Basel. |
2018-01-31 |
| Sanofi S.A.. (1/31/18). "Press Release: Sanofi, DNDi Seek European Medicines Agency Review for Sleeping Sickness Treatment". Paris & Geneva. |
2018-01-31 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 35 36 37 ... 67 68 69 
Date![Picture [iito] Männer Ballett 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-maenner-ballett.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
